arrow
M

Melanie Calvert

University of Birmingham
H指数:75
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

LB-525394-04 DISTRIBUTION OF ATRIAL FIBRILLATION BURDEN, RELATION TO OUTCOMES, AND EFFECTIVENESS AND SAFETY OF ANTICOAGULATION BASED ON DEVICE REPORTS: THE NOAH-AFNET 6 TRIAL

LB-525394-04 心房颤动负荷的分布、与结局的关系以及基于设备报告的抗凝治疗有效性和安全性:NOAH-AFNET 6 试验

2026-04-150
PRE
Designing and Implementing Real World Patient Reported Outcomes (RW- PROs) - Emerging Recommendations: A Good Practices Report of an ISPOR Task Force

设计与实施真实世界患者报告结局(RW-PROs)——新兴建议:ISPOR工作组的一份良好实践报告

2026-03-180
PRE
A practical toolkit with recommendations for analysing and visualising patient-reported outcomes in early phase dose-finding oncology trials (OPTIMISE-AR)

早期剂量探索性肿瘤临床试验中患者报告结局的分析与可视化实用工具包与建议(OPTIMISE-AR)

2026-03-170
PRE
Considerations for epidemiological studies investigating emerging post-acute infection syndromes: Long Covid as a case study

关于调查新兴急性感染后综合征的流行病学研究考虑:以长新冠为例

2026-03-160
OAAI
Health Equity Concerns in People with Sickle Cell Disease and Recurrent Vaso-Occlusive Crises: Results from an International Survey Study

镰状细胞病患者及反复血管闭塞性危象患者中的健康公平性问题:一项国际调查研究的成果

2025-11-010
OAAI
Patient and Caregiver Experiences of CAR T Cell Therapy for Blood Cancer in the UK: A Qualitative Study

英国血液癌患者及照护者对CAR T细胞疗法的体验:一项定性研究

2025-07-230
OAAI
Measure selection for an electronic patient-reported outcome (ePRO) system for CAR T-cell therapy patients: a modified Delphi consensus study

电子患者报告结局(ePRO)系统在CAR T细胞治疗患者中的应用:一项改良德尔菲共识研究

2025-06-010
OA
The risk of Long Covid symptoms: a systematic review and meta-analysis of controlled studies

O’Mahoney, L.L.; Routen, A.; Gillies, C.; Jenkins, S.A.; Almaqhawi, A.; Ayoubkhani, D.; Banerjee, A.; Brightling, C.; Calvert, M.; Cassambai, S.; 等. 长期新冠症状的风险:一项针对受控研究的系统评价和荟萃分析。Nat. Commun. 2025, 16, 4249. [Google Scholar] [CrossRef] [PubMed]

2025-05-070
OAAI
Mixed methods study of views and experience of non-hospitalised individuals with long COVID of using pacing interventions

混合方法研究:未住院的长期COVID患者对使用节律性干预措施的观点和体验

2025-04-250
OA
Recommendations to promote equity, diversity and inclusion in decentralized clinical trials

促进分散式临床试验的公平性、多样性和包容性的建议

2024-10-290
OA
Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials - insights from an expert virtual roundtable

推进以患者为中心的护理: 在早期临床试验中整合患者报告的结果进行耐受性评估-来自专家虚拟圆桌会议的见解

2024-10-010
OAAI